| Financial Year |
March 31 2023 |
| Monetary Funds |
392,961,056.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
94,481,551.76 |
| Advances to Suppliers |
127,535,773.68 |
| Other Receivables |
55,291,723.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
287,815,631.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,714,476.92 |
| Total Current Assets |
992,115,885.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
61,573,517.86 |
| Investment Properties |
125,796,060.76 |
| Fixed Assetes |
498,764,415.59 |
| Under-construction Projects |
1,969,975.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,690,217.27 |
| R&D expenses |
-- |
| Goodwill |
7,706,196.29 |
| Long-Term Deferred and Prepaid Expenses |
94,227,732.89 |
| Deferred Income Tax Assets |
16,717,680.86 |
| Other Non-Current Assets |
19,529,001.36 |
| Sub-Total of Non-Current Assets |
1,244,026,045.89 |
| Total Assets |
2,236,141,931.08 |
| Short-Term Loans |
685,905,349.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
153,782,859.33 |
| Accounts Received In Advance |
919,515.36 |
| Employee Compensation Payable |
34,191,632.24 |
| Taxes Payable |
3,387,305.17 |
| Interest Payable |
-- |
| Dividend Payable |
689,133.15 |
| Other payables |
97,080,786.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,097,572.04 |
| Other Current Liabilities |
5,761,773.23 |
| Sub-Total of Current Liabilities |
1,132,980,740.97 |
| Long-term Loans |
200,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
7,999,400.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
275,000.00 |
| Deferred Income Tax Liabilities |
6,864,491.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
488,135,064.91 |
| Total Liabilities |
1,621,115,805.88 |
| Paid-In Capital(Or Share Stock) |
236,747,901.00 |
| Capital Surplus |
398,207,209.02 |
| Surplus Reserve |
49,465,256.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-62,988,257.12 |
| Minority Stockholder's Interest |
-6,405,983.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
621,432,109.14 |
| Owner's Equity（Stockholder's Equity） |
615,026,125.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,236,141,931.08 |
